|
2015
|
Invention
|
Anti-il-4/anti-il-13 bispecific antibody/polyglutamate formulations. The present invention provid... |
|
2012
|
Invention
|
Composition for controlled release of buprenorphine. The present invention relates to a novel aqu... |
|
|
Invention
|
Composition for the controlled release of buprenorphine.
The present invention relates to a nove... |
|
|
Invention
|
Composition comprising interferon alpha. The present invention relates to a novel solid compositi... |
|
|
Invention
|
Composition comprising interferon alpha.
The present invention relates to a novel solid composit... |
|
2011
|
Invention
|
Method for the preparation of nanoparticles.
The present invention relates to a novel method for... |
|
|
Invention
|
Process for preparing nanoparticles of two polyamino acids of opposite charge, one of the two of ... |
|
|
Invention
|
Nanoparticles comprising at least one active agent and at least two polyelectrolytes. The present... |
|
|
Invention
|
Nanoparticles having at least one active ingredient and at least two polyelectrolytes.
The prese... |
|
|
Invention
|
Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for modifie... |
|
|
Invention
|
Multimicroparticulate pharmaceutical forms for oral administration.
The object of the present in... |
|
2010
|
Invention
|
Amphiphilic polymer functionalised by methionine. The present invention relates to novel amphiphi... |
|
|
Invention
|
Amphiphilic polymer functionalized by methionine.
The present invention relates to new amphiphil... |
|
|
Invention
|
Polymer of acrylic or methacrylic type comprising alpha-tocopherol grafts.
The present invention... |
|
|
Invention
|
Acrylic or methacrylic polymer including alpha-tocopherol grafts. The present invention relates t... |
|
|
Invention
|
Anti-misuse solid oral dosage form provided having a modified specific release profile. The prese... |
|
|
Invention
|
N-phosphonomethylglycine guanidine derivative salts. The present invention provides N-phosphonome... |
|
|
Invention
|
Method for preparing hollow particles, and uses thereof. The invention relates to a method for pr... |
|
|
Invention
|
Controlled-release floating pharmaceutical compositions. The invention relates to a pharmaceutica... |
|
2009
|
Invention
|
Composition including an active agent with low water solubility. The present invention relates to... |
|
|
Invention
|
Polyaminoacids functionalized wtih alpha-tocopherol, and uses thereof, especially therapeutic use... |
|
|
Invention
|
Anti-misuse microparticulate oral drug form.
The invention relates to solid microparticulate ora... |
|
|
Invention
|
Microparticulate oral drug form useful for the modified release of nanoparticles. The present inv... |
|
|
Invention
|
Microparticle oral form useful for the modified release of nanoparticles.
The present invention ... |
|
|
Invention
|
Solid oral form provided with a double release profile.
The present invention relates to a solid... |
|
|
Invention
|
Solid oral form with dual release profile, containing multiparticulates. The invention relates to... |
|
2008
|
Invention
|
Self-precipitating pharmaceutical formulations for the modified release of an active principle. T... |
|
|
Invention
|
Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof. The prese... |
|
|
Invention
|
Modified-release particles based on polyelectrolytes and on an active principle and pharmaceutica... |
|
|
Invention
|
Self-precipitating pharmaceutical formulations for the modified release of active principle. The ... |
|
|
Invention
|
Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications ther... |
|
2006
|
Invention
|
Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses th... |
|
|
Invention
|
Microparticles with modified release of at least one active principle and oral pharmaceutical for... |
|
|
Invention
|
Oral pharmaceutical for based on at least one active principle whose solubility varies as a funct... |
|
|
Invention
|
Oral medicament based on a proton pump inhibitor.
The invention relates to oral medicaments havi... |
|
|
Invention
|
Multimicroparticulate oral pharmaceutical form with modified release of angiotensin ii receptor a... |
|
|
Invention
|
Oral pharmaceutical form of losartan.
The field of the present invention is that of oral pharmac... |
|
|
Invention
|
Copolyhydroxyalkylglutamines functionalised with hydrophobic groups, and uses thereof, especially... |
|
2005
|
Invention
|
Solid, oral, microparticulate dosage form which has been designed to prevent misuse.
The inventi... |
|
|
Invention
|
Oral medicament for the modified release of at least one active principle, in multimicrocapsule f... |
|
|
Invention
|
Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications t... |
|
|
Invention
|
Branched polyamino acids functionalized with hydrophobic groups, and applications thereof particu... |
|
|
Invention
|
Long-acting colloidal insulin formulation and its preparation. The invention relates to injectabl... |
